Determination Of The Active Metabolite Of Prulifloxacin In Human Plasma By A 96-Well Format Solid-Phase Extraction And Capillary Zone Electrophoresis

Lingli Zhang,Dafang Zhong,Jun Wen,Yaju Pan,Guorong Fan

DOI: https://doi.org/10.1016/j.jchromb.2008.07.033

2008-01-01

Drug Metabolism Reviews

Abstract:This paper described a method for quantification of ulifloxacin, the active metabolite of prulifloxacin in human plasma by capillary zone electrophoresis using lomefloxacin as the internal standard. The separation was carried out at 25°C in a 60.2cm×75μm fused-silica capillary with an applied voltage of 20kV using 200mM borate buffer (pH 10.5). The detection wavelength was 275nm. Clean-up and preconcentration of the samples were developed by 96-well format solid-phase extraction. 0.25ml of plasma sample and 0.25ml of IS were loaded onto the preconditioned wells, and the wells were washed using 1ml of 20% methanol in acid water (1% phosphoric acid), and the analytes were eluted using 1ml of 95/5 methanol/ammonia water. The method was suitably validated with respect to stability, specificity, linearity, lower limit of quantitation, accuracy, precision, extraction recovery and robustness. The calibration graph was linear for ulifloxacin from 0.02 to 2μg/ml. The lower limit of quantification was 0.02μg/ml. The intra- and inter-day precisions were within 4.0 and 8.2%, respectively. The method developed was successfully applied to the evaluation of clinical pharmacokinetic study of prulifloxacin formulation product after oral administration to healthy volunteers.